Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Eris Lifesciences Q4 22 revenues at Rs 3,059 million, up 10 per cent YoY
Revenue for Q4 FY22 grew by 10 per cent YoY to Rs 3,059 million, and for FY22 grew by 11.2 per cent YoY to Rs 13,470 million
Zydus receives final approval from US FDA for Bortezomib for injection
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Alkem launches inhalation device – Innohaler for Asthma and COPD patients
Alkem is all set to fill the massive gap in accessibility for the treatment of respiratory diseases in India and has further made…
Ideaya Biosciences receives ODD for Darovasertib for treating uveal melanoma
Under the ODD, Ideaya may be entitled to certain tax credits, exemption from user fees, and seven years of statutory marketing…
WHO issues rapid communication on updated guidance to treat drug-resistant TB
These updates include shorter novel six-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB…
Alembic reports 11 per cent growth in revenue for Q4 FY22 from Rs 1,280 crores in FY21 to Rs 1,416…
Company recommended dividend of Rs 10 per equity share i.e. 500 per cent
IIT Mandi discovers molecule that might help in treating type-I and type-II diabetes
Researchers found that the molecule PK2 not only increases insulin release, but also prevents and reverses beta cell loss, making…
Avantor Foundation launches STEM Programming for Indian students
The initiative will include 15 schools in Thane district of Maharashtra impacting 3,000 students and 48 teachers
Biocon Q4FY22 revenue at Rs 2,476 crores, up 21 per cent
FY22 revenue at Rs 8,397 crores, up 14 per cent; core EBITDA up 18 per cent at Rs 2,669 crores; PBT (before Exceptional Item) at…
Taking India beyond ‘Pharmacy of the World’
A policy to incentivise pharma R&D is crucial as there are already signs that pharma R&D dives when revenues dip